Uma nova edição do CPSA Brasil – Clinical & Pharmaceutical Solutions through Analysis
acontecerá entre dias 1 e 3 de agosto no Club Transatlântico, São Paulo.
No primeiro dia do evento (1/8), o CEMSA promoverá um workshop gratuito, que ocorrerá paralelamente, intitulado The Momentum and Perspectives of Drug Discovery and Development in Brazil. As vagas são limitadas e a inscrição pode ser feita pelo e-mail [email protected].
O evento acontecerá no Auditório Trabulsi, localizado no Instituo de Ciências Biomédicas (Prédio III), na Av. Prof. Lineu Prestes, 1730 – Cidade Universitária, São Paulo, SP.
Confira a seguir algumas das palestras que serão apresentadas:
Pre-clinical and clinical development of two novel pharmaceutical products: Zilt and Nanorap, Gilberto De Nucci
From Drug Repositioning to Natural Products: Search for Novel Candidates Against neglected Protozoan Diseases, André Gustavo Tempone (Instituto Adolfo Lutz)
The Drug Discovery Process & the Role of Computational Chemistry, Gabriela Barreiro (Eurofarma)
Advancing Drug Discovery and Cell Biology Research with High-Content Screening, Luciane Ganiko (Molecular Devices)
Contributions of SiMBio-LINS group to Medicinal Chemistry, João Paulo dos Santos Fernandes (ICAQF-UNIFESP)
ADME and Pharmacokinetics in the development of new drugs, Michel Leandro de Campos (FCF-UNESP)
Clinical trials in cancer-bearing dogs and their impact on the development of new cancer therapies, Maria Lucia Dagli (FMVZ-USP)
Bridging the innovation gap: building academic-pharma consortia in Brazil, Lucio Freitas Junior
Discovery of new drug candidates in Brazil: how to innovate?, Kerly Pasqualoto (Alchemy)
Bridging the Gap between Academia and Industry: Radical Innovation from Brazilian Discoveries, Paulo Lacativa (BioZeus)
Clinical research: can we make it faster and cheaper?, Camille Rodrigues (Pharmagenix)